Cited by

• 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

  Kemp JA, Foster AC, Leeson PD, Priestley T, Tridgett R, Iversen LL, Woodruff GN. Kemp JA, et al. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6547-50. doi: 10.1073/pnas.85.17.6547. Proc Natl Acad Sci U S A. 1988. PMID: 2842779 Free PMC article.
• Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp: antagonism at the strychnine-insensitive glycine receptor.

  Hershkowitz N, Rogawski MA. Hershkowitz N, et al. Br J Pharmacol. 1989 Nov;98(3):1005-13. doi: 10.1111/j.1476-5381.1989.tb14632.x. Br J Pharmacol. 1989. PMID: 2556198 Free PMC article.
• Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.

  Singh L, Donald AE, Foster AC, Hutson PH, Iversen LL, Iversen SD, Kemp JA, Leeson PD, Marshall GR, Oles RJ, et al. Singh L, et al. Proc Natl Acad Sci U S A. 1990 Jan;87(1):347-51. doi: 10.1073/pnas.87.1.347. Proc Natl Acad Sci U S A. 1990. PMID: 2153294 Free PMC article.
• Cognitive effects of milacemide and methylphenidate in healthy young adults.

  Camp-Bruno JA, Herting RL. Camp-Bruno JA, et al. Psychopharmacology (Berl). 1994 Jun;115(1-2):46-52. doi: 10.1007/BF02244750. Psychopharmacology (Berl). 1994. PMID: 7862911 Clinical Trial.
• The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.

  Kretschmer BD, Zadow B, Volz TL, Volz L, Schmidt WJ. Kretschmer BD, et al. J Neural Transm Gen Sect. 1992;87(1):23-35. doi: 10.1007/BF01253108. J Neural Transm Gen Sect. 1992. PMID: 1346965